26 results
8-K
EX-1.1
NRBO
NeuroBo Pharmaceuticals Inc
8 Nov 22
Neurobo Announces Pricing of $30 Million Underwritten Public Offering and Concurrent Private Placement
5:24pm
agrees to pay on each of the Closing Date and each Option Closing Date, if any, to the extent not paid at the Closing Date, all expenses incident
8-K
EX-10.4
qr745nht 3aaur0747
14 Sep 22
Entry into a Material Definitive Agreement
5:11pm
8-K
EX-10.1
z689c9rw
4 Oct 21
Neurobo Pharmaceuticals Announces $14 Million Registered Direct Offering
4:46pm
424B3
0c2 3v2ki28i339bo
30 Apr 21
Prospectus supplement
5:13pm
424B3
7em8w0fe273jnn ol2rg
1 Feb 21
Prospectus supplement
4:19pm
424B3
fg82jrmp
29 Jan 21
Prospectus supplement
9:20am
8-K
EX-10.1
h3tij5jhzq ula
21 Jan 21
NeuroBo Pharmaceuticals Announces $10.0 Million Private Placement
5:03pm
8-K
EX-10.2
d1ymdg dq8o
21 Jan 21
NeuroBo Pharmaceuticals Announces $10.0 Million Private Placement
5:03pm
8-K
EX-10.1
8gx3bw
15 Apr 20
NeuroBo Pharmaceuticals Announces $7.5 Million Registered Direct Offering
5:13pm
8-K
EX-10.1
jxpby1 r31yvzjutp8x
13 Feb 20
Departure of Directors or Certain Officers
4:01pm
8-K
EX-99.1
r97g0m9v5642lqr gv
13 Jan 20
Regulation FD Disclosure
3:11pm